rs75654767

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001008212.2(OPTN):​c.1634G>A​(p.Arg545Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00137 in 1,614,042 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R545W) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0014 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0014 ( 30 hom. )

Consequence

OPTN
NM_001008212.2 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:8

Conservation

PhyloP100: -1.60

Publications

62 publications found
Variant links:
Genes affected
OPTN (HGNC:17142): (optineurin) This gene encodes the coiled-coil containing protein optineurin. Optineurin may play a role in normal-tension glaucoma and adult-onset primary open angle glaucoma. Optineurin interacts with adenovirus E3-14.7K protein and may utilize tumor necrosis factor-alpha or Fas-ligand pathways to mediate apoptosis, inflammation or vasoconstriction. Optineurin may also function in cellular morphogenesis and membrane trafficking, vesicle trafficking, and transcription activation through its interactions with the RAB8, huntingtin, and transcription factor IIIA proteins. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]
OPTN Gene-Disease associations (from GenCC):
  • glaucoma, normal tension, susceptibility to
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • amyotrophic lateral sclerosis type 12
    Inheritance: AR, AD, SD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Genomics England PanelApp
  • glaucoma 1, open angle, E
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03974253).
BP6
Variant 10-13136766-G-A is Benign according to our data. Variant chr10-13136766-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 7098.We mark this variant Benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00144 (219/152268) while in subpopulation EAS AF = 0.0338 (175/5176). AF 95% confidence interval is 0.0297. There are 6 homozygotes in GnomAd4. There are 130 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR,AD,SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OPTNNM_001008212.2 linkc.1634G>A p.Arg545Gln missense_variant Exon 15 of 15 ENST00000378747.8 NP_001008213.1 Q96CV9-1
OPTNNM_001008211.1 linkc.1634G>A p.Arg545Gln missense_variant Exon 16 of 16 NP_001008212.1 Q96CV9-1
OPTNNM_001008213.1 linkc.1634G>A p.Arg545Gln missense_variant Exon 16 of 16 NP_001008214.1 Q96CV9-1
OPTNNM_021980.4 linkc.1634G>A p.Arg545Gln missense_variant Exon 14 of 14 NP_068815.2 Q96CV9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OPTNENST00000378747.8 linkc.1634G>A p.Arg545Gln missense_variant Exon 15 of 15 1 NM_001008212.2 ENSP00000368021.3 Q96CV9-1

Frequencies

GnomAD3 genomes
AF:
0.00144
AC:
219
AN:
152150
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.0337
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00310
AC:
780
AN:
251396
AF XY:
0.00297
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000347
Gnomad ASJ exome
AF:
0.00437
Gnomad EAS exome
AF:
0.0345
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000255
Gnomad OTH exome
AF:
0.00244
GnomAD4 exome
AF:
0.00137
AC:
1998
AN:
1461774
Hom.:
30
Cov.:
32
AF XY:
0.00135
AC XY:
982
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33474
American (AMR)
AF:
0.000246
AC:
11
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00406
AC:
106
AN:
26132
East Asian (EAS)
AF:
0.0349
AC:
1387
AN:
39698
South Asian (SAS)
AF:
0.00161
AC:
139
AN:
86248
European-Finnish (FIN)
AF:
0.0000374
AC:
2
AN:
53414
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.000122
AC:
136
AN:
1111932
Other (OTH)
AF:
0.00348
AC:
210
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
113
226
339
452
565
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00144
AC:
219
AN:
152268
Hom.:
6
Cov.:
33
AF XY:
0.00175
AC XY:
130
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41552
American (AMR)
AF:
0.000262
AC:
4
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3472
East Asian (EAS)
AF:
0.0338
AC:
175
AN:
5176
South Asian (SAS)
AF:
0.00249
AC:
12
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000176
AC:
12
AN:
68018
Other (OTH)
AF:
0.00425
AC:
9
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00117
Hom.:
3
Bravo
AF:
0.00162
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.00290
AC:
352
Asia WGS
AF:
0.0180
AC:
64
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000356

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Primary open angle glaucoma Uncertain:1Benign:2
Mar 18, 2016
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:reference population

- -

Aug 22, 2023
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Amyotrophic lateral sclerosis type 12 Benign:2
Nov 05, 2023
Molecular Genetics, Royal Melbourne Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Glaucoma 1, open angle, E Pathogenic:1
Feb 08, 2002
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not specified Benign:1
Oct 31, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

OPTN-related disorder Benign:1
Jul 10, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Dec 02, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 31198474, 31182772, 17293779, 26566915, 11834836, 19172505, 20981092, 25333069, 15226658, 12939304, 22995991, 19672125) -

Primary open angle glaucoma;C1842026:Glaucoma 1, open angle, E;C3150692:Amyotrophic lateral sclerosis type 12 Benign:1
Dec 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
0.0030
DANN
Benign
0.78
DEOGEN2
Benign
0.063
T;.;T;.;T;T
Eigen
Benign
-2.3
Eigen_PC
Benign
-2.3
FATHMM_MKL
Benign
0.052
N
LIST_S2
Benign
0.68
.;.;.;T;.;T
MetaRNN
Benign
0.040
T;T;T;T;T;T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
-1.6
N;.;N;.;N;N
PhyloP100
-1.6
PrimateAI
Benign
0.22
T
PROVEAN
Benign
1.5
N;N;N;N;N;N
REVEL
Benign
0.22
Sift
Benign
1.0
T;T;T;T;T;T
Sift4G
Benign
1.0
T;T;T;T;T;T
Polyphen
0.0020
B;B;B;B;B;B
Vest4
0.12
MVP
0.81
MPC
0.20
ClinPred
0.016
T
GERP RS
-10
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.013
gMVP
0.21
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75654767; hg19: chr10-13178766; API